Key Developments and Challenges in Laboratory Networks
The current landscape of medical laboratory networks and challenges that will need to be addressed to improve data sharing and efficiency.
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
The current landscape of medical laboratory networks and challenges that will need to be addressed to improve data sharing and efficiency.
Despite the emergence and rise of new Omicron variants, COVID-19 testing has declined as much as 90 percent, according to some reports.
Recent developments suggest that we are on the precipice of a new age offering expanded options for Alzheimer’s diagnosis.
Recent study suggests those being treated for acute conditions are likelier to schedule follow-up appointments after telehealth visits.
Though it took longer than expected, the medtech industry and FDA have finally agreed on medical device user fees for the next five years.
Researchers find that three out of four blood tests produced different results depending on if they were used for White or Black people.
Senators recently introduced a bill that would require coverage for individuals with a family history of hereditary cancer.
Even when accounting for the impact of COVID-19, recent report suggests the future of direct-to-consumer genetic testing remains bright.
Guidelines on use of genetic testing for inherited cardiovascular diseases have been revised in accordance with 2022 testing technology.
With cyberattacks becoming increasingly common, the FDA has issued long-awaited draft guidance to help device makers deal with the threat.
On April 14, the FDA announced that, for the first time, it has granted Emergency Use Authorization for a COVID-19 breathalyzer test.